Beyonttra™ (acoramidis), the First Near-complete TTR Stabilizer (≥90%), Approved in Japan to Treat ATTR-CM
In the Japanese Phase 3 study, 0% mortality was reported over the 30-month treatment period and acoramidis was well-tolerated ...
Healio6h
FDA recap: First new treatment for stroke in 3 decades, generic rivaroxaban and more
The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
Lexeo Therapeutics (NASDAQ:LXEO) Receives Buy Rating from Chardan Capital
Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Chardan Capital in a research note issued to investors on Tuesday,Benzinga ...
University of Massachusetts Lowell20h
M.S. Thesis Defense in Biological Sciences: Alfredo Bongiorno 4/8
The Kennedy College of Sciences, Department of Biological Sciences, invites you to attend a Masters Thesis defense by Alfredo Bongiorno on "The Role of Key Tropomyosin-Troponin T Interactions in Thin ...
Zacks Investment Research on MSN9h
NTLA Genome-Editing Therapy Gets FDA's RMAT Tag for New Indication
Intellia Therapeutics NTLA announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) designation ...
Dorset RSPCA: 6 pets who are on the lookout for new homes
The RSPCA Ashley Heath Animal Centre in Ringwood and the West Dorset RSPCA branch in Dorchester have several pets looking for new homes ...